Chemical Structure : LT-540-717
Catalog No.: PC-25801Not For Human Use, Lab Use Only.
LT-540-717 is a potent, selective and orally available FLT3 inhibitor with IC50 of 0.62 nM, inhibits FLT3 mutations FLT3 (ITD), FLT3 (D835V), FLT3 (ITD, D835V), FLT3 (ITD, F69L) with IC50 of 18.22, 1.54, 0.58 and 1.61 nM, respectively.
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
LT-540-717 is a potent, selective and orally available FLT3 inhibitor with IC50 of 0.62 nM, inhibits FLT3 mutations FLT3 (ITD), FLT3 (D835V), FLT3 (ITD, D835V), FLT3 (ITD, F69L) with IC50 of 18.22, 1.54, 0.58 and 1.61 nM, respectively.
LT-540-717 displays <100-fold selectivity over CDK4/cycD3, CDK6/CycD1 and CDK7/CycH/MAT1, exhibits little inhibitory activity against other kinases.
LT-540-717 shows the strongest proliferation-inhibition efficacy against MV4-11 cells with IC50 of 0.02 uM.
LT-540-717 shows much more potent anti-proliferative activities against cell lines containing FLT3 (ITD) mutant (MV4-11 and MOLM-13) than cell lines containing wild-type FLT3 or expressing FLT3.
LT-540-717 (25 mg/kg, QD and 50 mg/kg, QD) exhibited antitumor efficacy in MV4-11 xenograft model.
| M.Wt | 456.51 | |
| Formula | C24H24N8O2 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Yanle Zhi, et al. Eur J Med Chem. 2023 Aug 5:256:115448.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright